ERBB2 and breast carcinoma: By stably overexpressing one of the four genes EGFR, HER2, RAF, or MEK in the estrogen receptor (ER)-positive MCF7 breast cancer cell line, Creighton and colleagues established cell lines with hyperactivation of the MAPK pathway [91].